-The Hindu How is it possible for a teacher to discipline a child even without scolding? I was born in a family of three daughters to parents who were not conversant in English. I was admitted to an Anglo-Indian School in Chennai in the middle level. The school had a lovely campus with a beautiful church inside. I did feel lost for some time, but I quickly fell into the groove mainly...

-The Hindu Cyber security threats have recently emerged as the new defining security challenge in a networked global Internet economy. This explains why National Security Adviser Shivshankar Menon and his deputy Vijay Latha Reddy Reddy are focussed on engaging the private sector. Like others with similar responsibilities, the national security administration is more deeply concerned about security breaches and attacks through computers, mobiles and other devices than a physical act of war,...

-The Hindu In the context of the ongoing debate on Kudankulam, the question of nuclear liability has come to the fore again. As a person who engaged with this question almost 50 years ago, I would like to throw some light on the subject. As a lead member of the Indian team negotiating the Tarapur contract with the Americans, it fell to my remit to address this matter. General Electric and...

-The Economist A new form of radical centrist politics is needed to tackle inequality without hurting economic growth BY THE end of the 19th century, the first age of globalisation and a spate of new inventions had transformed the world economy. But the “Gilded Age” was also a famously unequal one, with America’s robber barons and Europe’s “Downton Abbey” classes amassing huge wealth: the concept of “conspicuous consumption” dates back to 1899....

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...